Examkin

Soru

Zorluk: Çok zorPharmacologic Interventions

A 58-year-old man is treated in the intensive care unit for refractory septic shock secondary to a perforated viscus. Following initial resuscitation with 4 L4\text{ L} of intravenous lactated Ringer solution, he requires escalating doses of vasoactive agents. His current infusions include norepinephrine at 0.6 μg/kg/min0.6\ \mu\text{g/kg/min} and vasopressin at 0.04 units/min0.04\text{ units/min}. Despite these measures, his blood pressure is 76/40 mm Hg76/40\text{ mm Hg} (mean arterial pressure 52 mm Hg52\text{ mm Hg}). His heart rate is 142/min142/\text{min} and regular. Peripheral pulses are bounding. Point-of-care echocardiography demonstrates an underfilled left ventricular cavity, a hyperdynamic left ventricle with an estimated ejection fraction of 80%80\%, and systolic anterior motion of the mitral valve creating a dynamic left ventricular outflow tract gradient. Which of the following is the most appropriate next step in the pharmacologic management of this patient?

  1. A
    Add a dobutamine infusion
  2. B
    Add an epinephrine infusion
  3. Transition norepinephrine to a phenylephrine infusionCevap
  4. D
    Initiate empiric liposomal amphotericin B
  5. E
    Administer a continuous furosemide infusion

Cevap

Transition norepinephrine to a phenylephrine infusion.
The correct answer is to transition norepinephrine to a phenylephrine infusion. This patient has distributive shock complicated by dynamic left ventricular outflow tract (LVOT) obstruction. This phenomenon can occur in severely hypovolemic or vasodilated patients who develop a compensatory hyperdynamic left ventricle. The vigorous contraction of an underfilled ventricle causes systolic anterior motion (SAM) of the mitral valve leaflet, mechanically obstructing the LVOT and severely reducing cardiac output. In this state, medications with beta-1 adrenergic activity (such as norepinephrine, dobutamine, or epinephrine) worsen the obstruction by further increasing heart rate and contractility. The most appropriate pharmacologic intervention is to discontinue beta-1 stimulating agents and initiate a pure alpha-1 adrenergic agonist, such as phenylephrine. Phenylephrine increases systemic vascular resistance (afterload) without increasing contractility, which helps 'splint' the left ventricle open during systole, reducing the outflow gradient and restoring cardiac output.

Adım Adım Çözüm

1
Analyze the point-of-care echocardiography findings in the context of refractory shock.
Identify the presence of an underfilled, hyperdynamic left ventricle with systolic anterior motion (SAM) of the mitral valve.
This confirms the diagnosis of dynamic left ventricular outflow tract (LVOT) obstruction complicating distributive shock.
2
Evaluate the patient's current pharmacologic regimen against the mechanical complication.
Determine that norepinephrine provides beta-1 adrenergic stimulation (inotropy and chronotropy), which actively worsens SAM and the LVOT gradient.
Beta-1 agonists increase the vigor of ventricular contraction, forcefully pulling the anterior mitral leaflet into the outflow tract in an underfilled heart.
3
Select the optimal hemodynamic goals and corresponding pharmacologic intervention.
Choose to increase afterload and decrease contractility by transitioning from a mixed alpha/beta agonist (norepinephrine) to a pure alpha-1 agonist (phenylephrine).
Pure alpha-1 agonists increase systemic vascular resistance without stimulating the heart, splinting the left ventricle open during systole and relieving the obstruction.

Anahtar Kavram

In dynamic left ventricular outflow tract obstruction complicating distributive shock, beta-1 agonists worsen the obstruction, whereas pure alpha-1 agonists (like phenylephrine) improve hemodynamics by increasing afterload and relieving the gradient.
Bu soruyu puanla

Konular

Pharmacologic Interventions

Bu konudan daha fazla soru